| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/05/2007 | US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering |
| 06/05/2007 | US7226757 Adding to the protein an aqueous solution of a charged polymer to reduce intermolecular or intramolecular interactions between positively and negatively charged domains; refolding |
| 06/05/2007 | US7226620 and a binder comprising a polyvinylpyrollidone, carrageenan, or a guar gum; chewable oral dosage form |
| 06/05/2007 | US7226619 filler material inactivates opioid pro-agonist medication if the pharmaceutical dosage form is dissolved in vitro; pro-agonist medication being metabolizable in vivo to an agonist following administration |
| 06/05/2007 | US7226618 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 06/05/2007 | US7226617 Thermosensitive and biodegradable microgel and a method for the preparation thereof |
| 06/05/2007 | US7226616 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 06/05/2007 | US7226615 kit for forming a solid cellular foam proteinaceous biopolymeric material comprising separate reactable aliquot portions; employed to grow tissue and for achieving hemostasis |
| 06/05/2007 | US7226614 segmented; sustained release; for treatment of allergies |
| 06/05/2007 | US7226613 Seamless filled capsules |
| 06/05/2007 | US7226608 Skin and hair sunblocks; smooth, uniform, lustrous, visually appealing, healthy look; dispersion of calcined alumina, stainless steel, or gold particles |
| 06/05/2007 | US7226590 Antimicrobial composition |
| 06/05/2007 | US7226589 Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor |
| 06/05/2007 | US7226586 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 06/05/2007 | US7226580 Topical compositions with an oily outer phase and process for their preparation |
| 06/05/2007 | US7226485 Prosthetic foot with tunable performance |
| 06/05/2007 | US7226442 Microchip reservoir devices using wireless transmission of power and data |
| 06/05/2007 | CA2286003C Phosphate-binding polymer preparation |
| 06/05/2007 | CA2268187C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 06/05/2007 | CA2181165C Anti-fungal methods and materials |
| 05/31/2007 | WO2007062414A1 Hydrogel sheets and shapes for oral care |
| 05/31/2007 | WO2007062266A2 Ganaxolone formulations and methods for the making and use thereof |
| 05/31/2007 | WO2007062262A2 Gelatinous medicament formulation and method of administration |
| 05/31/2007 | WO2007062228A1 Sustained-release formulation of zonisamide |
| 05/31/2007 | WO2007062107A2 Immunostimulatory oligoribonucleotides |
| 05/31/2007 | WO2007062076A2 Dexrazoxane formulations and methods |
| 05/31/2007 | WO2007062060A2 Methods and compositions using substance p to promote wound healing |
| 05/31/2007 | WO2007062023A2 Items containing a human pheromone component |
| 05/31/2007 | WO2007061829A2 Pharmaceutical composition |
| 05/31/2007 | WO2007061828A2 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | WO2007061820A2 Dissolution of arterial cholesterol plaques by a class of pharmacological compounds |
| 05/31/2007 | WO2007061781A1 Coatable compositions, coatings derived therefrom and microarrays having such coatings |
| 05/31/2007 | WO2007061739A2 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | WO2007061529A1 Lyophilization process and products obtained thereby |
| 05/31/2007 | WO2007061415A1 Pharmaceutical compositions of telmisartan |
| 05/31/2007 | WO2007061277A1 Corneal preservation medium |
| 05/31/2007 | WO2007061028A1 Gel composition for sterilization |
| 05/31/2007 | WO2007060802A1 Solid pharmaceutical preparation and pharmaceutical preparation composition |
| 05/31/2007 | WO2007060540A1 Stable dosage forms of an antidepressant |
| 05/31/2007 | WO2007060512A2 Compositions containing topical active agents and pentylene glycol |
| 05/31/2007 | WO2007060413A1 Treatment of sub-gingival pocket infections |
| 05/31/2007 | WO2007060407A2 Methods of stabilizing unconsolidated subterranean formations |
| 05/31/2007 | WO2007060402A1 Pharmaceutical compositions |
| 05/31/2007 | WO2007060384A2 Respirable powders |
| 05/31/2007 | WO2007060208A2 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same |
| 05/31/2007 | WO2007060177A1 Oil-in-water emulsion and its use for the delivery of functionality |
| 05/31/2007 | WO2007060108A2 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060107A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060106A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060105A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060104A2 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007059953A1 Formulation comprising a polyphenol-containing composition and isomaltulose |
| 05/31/2007 | WO2007059852A1 Ph-switchable transmembrane peptides as stimulators of membrane fusion |
| 05/31/2007 | WO2007059649A1 Chinese pharmaceutical compositions for treating upper respiratory tract infection and processes for preparation thereof |
| 05/31/2007 | WO2007059586A1 Nanoporous membrane and method of preparation thereof |
| 05/31/2007 | WO2007041475A3 Iontophoresis drug delivery formulation providing acceptable sensation and dermal anesthesia |
| 05/31/2007 | WO2007038386A8 Method for enhancing immune responses in mammals |
| 05/31/2007 | WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same |
| 05/31/2007 | WO2007035939A3 High enhancer-loading polyacrylate formulation for transdermal applications |
| 05/31/2007 | WO2007035348A3 Nanoparticulate aripiprazole formulations |
| 05/31/2007 | WO2007033316A3 Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| 05/31/2007 | WO2007031520A3 Use of octenidine dihydrochloride in semisolid preparations |
| 05/31/2007 | WO2007031519A3 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes |
| 05/31/2007 | WO2007029268A3 Stable oxaliplatin formulation |
| 05/31/2007 | WO2007028020A3 Liposome compositions |
| 05/31/2007 | WO2007022956A3 Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent |
| 05/31/2007 | WO2007021666A3 Liquid formulations |
| 05/31/2007 | WO2007019549A3 Composition and method for use in cartilage affecting conditions |
| 05/31/2007 | WO2007019393A3 Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties |
| 05/31/2007 | WO2007017248A3 Itraconazole compositions with improved bioavailability |
| 05/31/2007 | WO2007016350A3 Modified release tablet formulations with enhanced mechanical properties |
| 05/31/2007 | WO2007014393A3 Amorphous efavirenz and the production thereof |
| 05/31/2007 | WO2007013047A3 Water-dispersible anti-retroviral pharmaceutical compositions |
| 05/31/2007 | WO2007012968A3 Stable dosage form of an antidepressant |
| 05/31/2007 | WO2007012080A3 Oral care composition |
| 05/31/2007 | WO2007005633A3 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 05/31/2007 | WO2006127738A9 Compressible chewing gums for delivery of actives |
| 05/31/2007 | WO2006127616A9 Indicia-bearing package for delivery systems for managing release of flavors in an edible composition |
| 05/31/2007 | WO2006124749A3 Multilayer drug delivery system with barrier against antagonist exposure |
| 05/31/2007 | WO2006122165A3 Ocular therapy using alpha-2 adrenergic receptor agonists having enhanced anterior clearance rates |
| 05/31/2007 | WO2006119153A3 Timed, pulsatile release systems |
| 05/31/2007 | WO2006106514A3 Electrospun dosage form and method of producing the same |
| 05/31/2007 | WO2006103657A3 A solid composition for intra-oral delivery of insulin |
| 05/31/2007 | WO2006102163A3 Transfection reagents for non-adherent suspension cells |
| 05/31/2007 | WO2006089108A3 Method and apparatus for supplying gas to an area |
| 05/31/2007 | WO2006047198A3 Composition and method for using a cytokine to treat restenosis |
| 05/31/2007 | WO2006010155A8 Gonadotropin releasing hormone antagonists |
| 05/31/2007 | WO2005123047A3 Methods of managing multi-tissue injuries |
| 05/31/2007 | WO2005112899A3 Methods and systems for providing an interface between an ambulatory medical device and a display device |
| 05/31/2007 | WO2005032483A3 Polysaccharides for pulmonary delivery of active agents |
| 05/31/2007 | WO2002094185A3 Conjugates and compositions for cellular delivery |
| 05/31/2007 | US20070123843 Implantable drug delivery pump |
| 05/31/2007 | US20070123583 Using low dose of a microtubule stabilizing agent such as taxol; prevents artery blockage while minimizing any negative side effects |
| 05/31/2007 | US20070123554 Pyrazoloacrydone derivative-containing solution |
| 05/31/2007 | US20070123516 Method of treating mucus hypersecretion |
| 05/31/2007 | US20070123100 Coaxial connector having detachable locking sleeve |
| 05/31/2007 | US20070122488 Multi-functional microcapsules and method and device for manufacturing same |
| 05/31/2007 | US20070122487 (Poly(acryloyl-hydroxyethyl starch)-plga composition microspheres |
| 05/31/2007 | US20070122486 Nanoparticulate insulin |
| 05/31/2007 | US20070122485 Organic compounds |